Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Extendicare Inc.TSX: EXE.TO

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue remains negative

Q2 FY2026 cost of revenue was CA$0, compared with CA$337.03M a year earlier. Trailing-twelve-month cost of revenue was CA$1.2B. Over 3 fiscal years it compounded at +8.5% a year.

Context

  • Cost of revenue amounted to 88.0% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly cost of revenue holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$299.34M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
CA$0-100.0% QoQ
Last fiscal yearDec 2025
CA$1.46B+12.5% YoY
LTMJun 2026
CA$1.2B-9.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+12.5%——
3-year CAGR+8.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

CAD · from the income statement

Latest · FY2025
1.46B CAD
Year-over-year change
+12.5%
4-year CAGR
+8.6%

Cost of Revenue vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -9.7% is the lowest of 7, against a peer median of +13.9%.
  • Cost of revenue amounts to 60.5% of revenue for EXE.TO, versus a peer median of 67.7%.
EXE.TO Competitors
Cost of Revenue for EXE.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$1.2B CAD-9.7%+8.5%60.5%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$954.54M CAD+19.7%+14.2%85.9%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$929.1M CAD+49.5%+48.8%63.0%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$620.72M USD+5.1%+4.3%72.3%
CRRX.TOCareRx CorporationLTM Mar 2026CA$275.44M CAD+6.6%+0.7%73.5%
DR.TOMedical Facilities CorporationLTM Mar 2026$168.32M USD+61.4%+3.7%55.1%
CRON.TOCronos Group Inc.LTM Mar 2026$92.19M USD+8.1%+6.7%57.8%
Peer median (excluding EXE.TO) —+13.9%+5.5%67.7%

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B1.22B1.3B1.47B1.66B
Cost of Revenue1.05B1.14B1.14B1.3B1.46B
Gross Profit115.61M76.83M167.62M168M199.59M
Gross Margin9.9%6.3%12.8%11.5%12.0%
Research & Development00000
Selling, General & Admin69.79M51.08M55.84M1.2B1.36B
Operating Expenses52.43M50.78M55.84M56.94M61.22M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
EBITDA75M49.33M98.63M155.27M175.61M
EBITDA Margin6.4%4.0%7.6%10.6%10.6%
Operating Income49.71M20.99M62.96M111.21M138.37M
Operating Margin4.3%1.7%4.8%7.6%8.3%
Interest Income1.87M5.02M6.19M7.04M5.73M
Interest Expense22.45M21.7M21.6M21.1M19.23M
Other Income / Expenses(35.72M)(25.48M)(18.16M)(11.35M)(8.26M)
Income Before Tax13.99M(4.5M)44.8M99.86M130.1M
Pre-Tax Margin1.2%-0.4%3.4%6.8%7.8%
Income Tax Expense6.48M15K10.82M24.65M33.45M
Net Income11.5M69.55M33.98M75.21M96.66M
Net Margin1.0%5.7%2.6%5.1%5.8%
EPS (Basic)0.130.850.400.971.13
EPS (Diluted)0.130.850.400.861.11
Weighted Avg Shares89.99M89.01M84.99M84.22M85.4M
Weighted Avg Shares (Diluted)100.9M89.01M84.99M95.36M86.84M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.